Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Clinical trial NCT00030576 · COMPLETED
Trial details
- NCT number
- NCT00030576
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Primary completion
- 2009-12-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.